Results 191 to 200 of about 19,552 (331)

The Efficacy of Pharmacological Treatment of Depression in Anorexia Nervosa and Underweight Patients: A Systematic Review

European Eating Disorders Review, Volume 34, Issue 1, Page 55-70, January 2026.
ABSTRACT Objective Major depressive disorder (MDD) is a frequent comorbidity in anorexia nervosa (AN). This review aimed to evaluate evidence on the effectiveness of pharmacological treatments for MDD in underweight individuals. Method A systematic review was conducted using PubMed, Medline, PsycINFO, and Web of Science through March 2025.
M. J. Besjes, S. H. W. Mares, A. A. van Elburg, J. Spijker   +3 more
wiley   +1 more source

Psychotropic Medication Exposure via Breast Milk: A Population-Based Descriptive Study in Denmark. [PDF]

Paediatr Perinat Epidemiol
Liu X, Madsen KB, Zhu JL, Munk-Olsen T, Damkier P, Lupattelli A, Zoega H, Nordeng H, Kjeldsen MZ, Mægbæk ML, Madsen MG, Bergink V, Bliddal M.   +12 more
europepmc   +1 more source

Is Addiction Research Addicted to Artificial Intelligence? Mapping the Intersection of Artificial Intelligence, Substance Use and Mental Health Through a Bibliometric Analysis

Drug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Issues From extracting insights from large‐scale, multimodal data to prevention and support, there is growing interest in the applications and implications of recent advances in Artificial Intelligence (AI) within the fields of addiction, substance use and mental health, which we refer to as ASUM.
Loïs Vanhée, Simone Scarpa
wiley   +1 more source

Correlations between the prescribing patterns of psychotropic medications and socio-economic factors during the COVID-19 pandemic: A cross-sectional Swedish registry study. [PDF]

PLoS One
Ei D, Brådvik G, Lindgren P, Barach P, Bochenek T.   +4 more
europepmc   +1 more source

A drug education manual concerning illicit drugs and psychotropics - For teachers in secondary schools in the Member States of the European Community. Medicine. EUR 10594 EN [PDF]

, 1986
Basso, F., Casselman, J., Moorthamer, L., Van Hende, L.   +3 more
core  

The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction—A Narrative Review

Drug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Issues In Australia, detections of novel benzodiazepines (NBZ) and related overdoses have increased markedly over the last five years. This review summarises Australian peer‐reviewed literature and NBZ‐related drug alerts, outlines the pharmacology of commonly detected NBZs and discusses approaches to harm reduction, managing toxicity ...
Jack Freestone, Stassi Kypri, Jennifer L. Schumann, Erica Franklin, Cameron Francis, Monica J. Barratt, Amy Peacock, Rachel Sutherland, Brendan Clifford, Harriet MacDonald, Nadine Ezard, Kathryn Fletcher, Liam Acheson, Krista J. Siefried   +13 more
wiley   +1 more source

Sleep Disorders and the Elderly: The Effect of Progressive Relaxation Training Versus Sedative-Hypnotic Treatment on Insomnia

, 1989
Klaus J. Sauerbrey
openalex   +1 more source

Risk of depression with GLP‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 197-209, January 2026.
Abstract Aims The association between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and depression remains uncertain due to contradictory evidence. We compared the risk of incident depression between GLP‐1 RAs and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) in overweight or obese adults with type 2 diabetes.
Yu Chang, Ming‐Hong Hsieh, Po‐Chung Ju, Cheng‐Chen Chang   +3 more
wiley   +1 more source

Relationship Between Vertigo and Consumption of Psychotropic Drugs: A Prospective Case-Control Study. [PDF]

J Clin Med
Sánchez-Sellero I, Soto-Varela A.
europepmc   +1 more source

Residual Effects of Acute and Subchronic Zolpidem Treatments on Attentional Processes in Aged Female Rats

Fundamental &Clinical Pharmacology, Volume 40, Issue 1, January 2026.
ABSTRACT Rational Zolpidem, a hypnotic Z‐drug commonly prescribed to promote sleep, is predominantly used over the age of 50. In this elderly population, adverse behavioral disturbances, impaired driving performance, and an increased risk of falls have been frequently reported.
Marianne Leger, Michel Boulouard, Christophe Liet, Ben Grayson, Michael Harte, Joanna C. Neill, Marie‐Laure Bocca, Véronique Lelong‐Boulouard   +7 more
wiley   +1 more source